$1.86M OptumRx Settlement Ends Litigation Over Alleged Prerecorded Voice Messages

New to ClassAction.org? Read our Newswire Disclaimer

OptumRx has agreed to a $1,860,000 settlement to resolve a class action lawsuit that alleged the pharmacy sent prerecorded voice messages to consumers’ cell phones and Voice over Internet Protocol (VoIP) lines in violation of the federal Telephone Consumer Protection Act (TPCA).

Don’t miss out on class action settlement news like this. Sign up for ClassAction.org’s free weekly newsletter.

The OptumRx TCPA class action settlement received preliminary approval from the court on October 22, 2025 and covers any United States resident who is not or was not an OptumRx customer or account holder but received a clinical adherence call from OptumRx (not in connection to prescription reminders or COVID-19 vaccines) that used an artificial or prerecorded voice sent to their cell phone or VoIP line between April 20, 2020 and October 22, 2025. Per court documents, approximately 155,244 unique telephone numbers are potentially covered by the OptumRx settlement.

The court-approved website for the OptumRx class action settlement can be found at OptumRxTCPAClassActionSettlement.com.

According to the settlement website, OptumRx settlement class members who submit a timely, valid claim form are eligible to receive a one-time, pro-rated cash payment estimated to be between $72 and $135. The final amount each eligible class member receives will depend on the total number of valid claims that are filed and the remaining amount in the settlement fund after the payment of settlement administration expenses, attorneys’ fees and lead plaintiff service awards, the agreement notes.

Importantly, the settlement agreement adds that class members may submit only one claim form, regardless of how many times they were called or how many prerecorded messages were left.  

To submit an OptumRx settlement claim form, class members can head to this page and enter the unique class member ID as found on their copy of the settlement notice. Alternatively, class members can download a PDF claim form from the settlement website to print, fill out, and return by mail to the settlement administrator listed on the first page.

All OptumRx TCPA settlement claim forms must be submitted online or postmarked by February 4, 2026.

The court will determine whether to grant final approval to the OptumRx settlement at a hearing on March 31, 2026. Compensation will begin to be distributed only after final approval is granted and any appeals are resolved.

The OptumRx TCPA class action lawsuit alleged that the pharmaceutical services company left prerecorded voice messages on consumers’ cell phones or VoIP services in violation of the Telephone Consumer Protection Act. These messages, the complaint claimed, regarded clinical dosage adherences and were sent to consumers who did not have an OptumRx account.

Did you know that some class action settlements require no proof to submit a claim? Check out the latest open class action settlements.